Home/Filings/4/0001493152-23-031680
4//SEC Filing

Frelick Jeff 4

Accession 0001493152-23-031680

CIK 0001419554other

Filed

Sep 4, 8:00 PM ET

Accepted

Sep 5, 5:05 PM ET

Size

4.9 KB

Accession

0001493152-23-031680

Insider Transaction Report

Form 4
Period: 2023-08-31
Frelick Jeff
Chief Executive Officer
Transactions
  • Purchase

    Common Stock

    2023-08-31$0.66/sh+7,600$5,0207,704 total
Footnotes (1)
  • [F1]Includes 104 shares of vested restricted stock that were inadvertently reported in Table II at the time of grant.

Documents

1 file

Issuer

Bone Biologics Corp

CIK 0001419554

Entity typeother

Related Parties

1
  • filerCIK 0001645093

Filing Metadata

Form type
4
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 5:05 PM ET
Size
4.9 KB